1. Home
  2. ELTX vs CIK Comparison

ELTX vs CIK Comparison

Compare ELTX & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • CIK
  • Stock Information
  • Founded
  • ELTX 2011
  • CIK 1987
  • Country
  • ELTX United States
  • CIK United States
  • Employees
  • ELTX N/A
  • CIK N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • CIK Finance/Investors Services
  • Sector
  • ELTX Health Care
  • CIK Finance
  • Exchange
  • ELTX Nasdaq
  • CIK Nasdaq
  • Market Cap
  • ELTX 158.5M
  • CIK 157.6M
  • IPO Year
  • ELTX N/A
  • CIK N/A
  • Fundamental
  • Price
  • ELTX $9.13
  • CIK $2.87
  • Analyst Decision
  • ELTX Strong Buy
  • CIK
  • Analyst Count
  • ELTX 1
  • CIK 0
  • Target Price
  • ELTX $13.00
  • CIK N/A
  • AVG Volume (30 Days)
  • ELTX 102.3K
  • CIK 115.4K
  • Earning Date
  • ELTX 11-07-2025
  • CIK 01-01-0001
  • Dividend Yield
  • ELTX N/A
  • CIK 9.03%
  • EPS Growth
  • ELTX N/A
  • CIK N/A
  • EPS
  • ELTX N/A
  • CIK N/A
  • Revenue
  • ELTX N/A
  • CIK N/A
  • Revenue This Year
  • ELTX N/A
  • CIK N/A
  • Revenue Next Year
  • ELTX N/A
  • CIK N/A
  • P/E Ratio
  • ELTX N/A
  • CIK N/A
  • Revenue Growth
  • ELTX N/A
  • CIK N/A
  • 52 Week Low
  • ELTX $4.60
  • CIK $2.50
  • 52 Week High
  • ELTX $12.62
  • CIK $3.19
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 34.25
  • CIK 40.43
  • Support Level
  • ELTX $9.03
  • CIK $2.82
  • Resistance Level
  • ELTX $9.55
  • CIK $2.89
  • Average True Range (ATR)
  • ELTX 0.46
  • CIK 0.02
  • MACD
  • ELTX -0.04
  • CIK 0.00
  • Stochastic Oscillator
  • ELTX 9.65
  • CIK 56.25

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

About CIK Credit Suisse Asset Management Income Fund Inc.

Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.

Share on Social Networks: